Loading...
Fulgent Genetics, Inc.
FLGT•NASDAQ
Healthcare
Medical - Diagnostics & Research
$18.37
$-0.04(-0.22%)
Fulgent Genetics, Inc. (FLGT) Financial Performance & Income Statement Overview
Review Fulgent Genetics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.99%
↓ 1.99%
Operating Income Growth
-1.68%
↓ 1.68%
Net Income Growth
74.55%
↑ 74.55%
Operating Cash Flow Growth
-22.01%
↓ 22.009%
Operating Margin
-21.89%
↓ 21.89%
Gross Margin
38.12%
↑ 38.12%
Net Profit Margin
-13.94%
↓ 13.94%
ROE
-3.60%
↓ 3.60%
ROIC
-5.62%
↓ 5.62%
Fulgent Genetics, Inc. (FLGT) Income Statement & Financial Overview
Review Fulgent Genetics, Inc.'s (FLGT) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $76.21M | $71.74M | $71.03M | $64.48M |
| Cost of Revenue | $44.37M | $44.97M | $46.53M | $44.37M |
| Gross Profit | $31.85M | $26.77M | $24.50M | $20.11M |
| Gross Profit Ratio | $0.42 | $0.37 | $0.34 | $0.31 |
| R&D Expenses | $12.11M | $11.78M | $13.49M | $11.43M |
| SG&A Expenses | $33.88M | $30.07M | $29.92M | $30.48M |
| Operating Expenses | $47.98M | $43.85M | $43.41M | $41.91M |
| Total Costs & Expenses | $92.35M | $88.82M | $89.93M | $86.28M |
| Interest Income | $8.29M | $8.09M | $7.69M | $7.63M |
| Interest Expense | $210000.00 | $14000.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $6.19M | $5.92M | $6.15M | $6.66M |
| EBITDA | -$9.94M | -$12.60M | -$12.75M | -$15.13M |
| EBITDA Ratio | -$0.13 | -$0.18 | -$0.18 | -$0.23 |
| Operating Income | -$16.14M | -$17.08M | -$18.91M | -$21.80M |
| Operating Income Ratio | -$0.21 | -$0.24 | -$0.27 | -$0.34 |
| Other Income/Expenses (Net) | $8.09M | -$1.45M | $7.69M | $7.63M |
| Income Before Tax | -$8.04M | -$18.53M | -$11.21M | -$14.17M |
| Income Before Tax Ratio | -$0.11 | -$0.26 | -$0.16 | -$0.22 |
| Income Tax Expense | -$1.85M | -$3.84M | -$2.12M | -$327000.00 |
| Net Income | -$5.89M | -$14.65M | -$8.71M | -$13.46M |
| Net Income Ratio | -$0.08 | -$0.20 | -$0.12 | -$0.21 |
| EPS | -$0.19 | -$0.48 | -$0.29 | -$0.45 |
| Diluted EPS | -$0.19 | -$0.48 | -$0.29 | -$0.45 |
| Weighted Avg Shares Outstanding | $30.65M | $30.42M | $30.10M | $29.77M |
| Weighted Avg Shares Outstanding (Diluted) | $30.65M | $30.42M | $30.10M | $29.77M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan